Integra LifeSciences IART Less: Fair value of plan assets at end of period
Less: Fair value of plan assets at end of period at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:DefinedBenefitPlanFairValueOfPlanAssets.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's less: fair value of plan assets at end of period.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's less: fair value of plan assets at end of period?
- Integra LifeSciences (IART) reported less: fair value of plan assets at end of period of $71.1M in Q1 2026.
- How has Integra LifeSciences's less: fair value of plan assets at end of period changed year-over-year?
- Integra LifeSciences's less: fair value of plan assets at end of period increased by 30.7% year-over-year, from $54.4M to $71.1M.
- What is the long-term trend for Integra LifeSciences's less: fair value of plan assets at end of period?
- Over 5 years (2020 to 2025), Integra LifeSciences's less: fair value of plan assets at end of period has grown at a 13.7% compound annual growth rate (CAGR), from $37.8M to $71.7M.